Media Summary: SUBSCRIBE to ⁨⁩ to see more videos. Details and supporting materials: ... Presenters Changning Guo, Xiaoming Xu, and Meng Hu respond to audience questions. Learn more at ... Xiaoming Xu from the CDER Office of Pharmaceutical Division of Product Quality provides an overview of research, development, ...

Fda Crcg Mastering Particle Size Analysis Workshop Day Two Q A Session With Panel Closing - Detailed Analysis & Overview

SUBSCRIBE to ⁨⁩ to see more videos. Details and supporting materials: ... Presenters Changning Guo, Xiaoming Xu, and Meng Hu respond to audience questions. Learn more at ... Xiaoming Xu from the CDER Office of Pharmaceutical Division of Product Quality provides an overview of research, development, ... Liang Zhao, Yaning Wang, Robert Lionberger, and Murray Ducharme from Learn and Confirm, Inc., respond to audience ... Bryan Newman, Denise Conti, Kimberly Witzmann, Tian Ma, Fang Yuan, and Bhagwant Rege respond to audience questions. In Critical Path Institute's (C-Path) Global Impact Conference 2024, Executive Director of C-Path's Duchenne Regulatory Science ...

Photo Gallery

FDA-CRCG Mastering Particle Size Analysis Workshop: Day Two Q&A Session with Panel & Closing
FDA-CRCG Mastering Particle Size Analysis Workshop: Welcome, Opening Remarks, and Workshop Overview
FDA Mastering Particle Size Analysis Workshop: Industry Perspectives on Particle Size Measurement
Day 1 Welcome/Opening Remarks, Workshop Overview, Session 1 and 2 Presentations
Panel for Advanced Analytical and Statistical Methods for Assessing Particle Size Distributions
GDF2025 - D2S09 - Questions & Panel Discussion - Session Two
Day 2 FDA
Complex Product Characterization/Analysis - Session 2B
GPX.2: Using P-PSD™ to Fit Product Particle Size for In Vivo Dissolution Prediction
AGDD 2024 | D2S04 - Q&A Discussion Panel 1
Considerations of Particle Analysis (12of35) Complex Generics – Sep. 25-26, 2019
Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019
Sponsored
Sponsored
View Detailed Profile
FDA-CRCG Mastering Particle Size Analysis Workshop: Day Two Q&A Session with Panel & Closing

FDA-CRCG Mastering Particle Size Analysis Workshop: Day Two Q&A Session with Panel & Closing

SUBSCRIBE to ⁨@FDALearningCache⁩ to see more videos. Details and supporting materials: ...

FDA-CRCG Mastering Particle Size Analysis Workshop: Welcome, Opening Remarks, and Workshop Overview

FDA-CRCG Mastering Particle Size Analysis Workshop: Welcome, Opening Remarks, and Workshop Overview

SUBSCRIBE to ⁨@FDALearningCache⁩ to see more videos. Details and supporting materials: ...

Sponsored
FDA Mastering Particle Size Analysis Workshop: Industry Perspectives on Particle Size Measurement

FDA Mastering Particle Size Analysis Workshop: Industry Perspectives on Particle Size Measurement

SUBSCRIBE to ⁨@FDALearningCache⁩ to see more videos. Details and supporting materials: ...

Day 1 Welcome/Opening Remarks, Workshop Overview, Session 1 and 2 Presentations

Day 1 Welcome/Opening Remarks, Workshop Overview, Session 1 and 2 Presentations

Session

Panel for Advanced Analytical and Statistical Methods for Assessing Particle Size Distributions

Panel for Advanced Analytical and Statistical Methods for Assessing Particle Size Distributions

Presenters Changning Guo, Xiaoming Xu, and Meng Hu respond to audience questions. Learn more at ...

Sponsored
GDF2025 - D2S09 - Questions & Panel Discussion - Session Two

GDF2025 - D2S09 - Questions & Panel Discussion - Session Two

The Generic Drugs Forum's second of four

Day 2 FDA

Day 2 FDA

Day 2

Complex Product Characterization/Analysis - Session 2B

Complex Product Characterization/Analysis - Session 2B

A presentation and

GPX.2: Using P-PSD™ to Fit Product Particle Size for In Vivo Dissolution Prediction

GPX.2: Using P-PSD™ to Fit Product Particle Size for In Vivo Dissolution Prediction

GastroPlus X.

AGDD 2024 | D2S04 - Q&A Discussion Panel 1

AGDD 2024 | D2S04 - Q&A Discussion Panel 1

The first of three

Considerations of Particle Analysis (12of35) Complex Generics – Sep. 25-26, 2019

Considerations of Particle Analysis (12of35) Complex Generics – Sep. 25-26, 2019

Xiaoming Xu from the CDER Office of Pharmaceutical Division of Product Quality provides an overview of research, development, ...

Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019

Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019

Liang Zhao, Yaning Wang, Robert Lionberger, and Murray Ducharme from Learn and Confirm, Inc., respond to audience ...

GDF 2024 | D2S05 – Q&A Discussion Panel 1

GDF 2024 | D2S05 – Q&A Discussion Panel 1

The first of four

Panel Questions and Discussion (28of35) Complex Generics – Sep. 25-26, 2019

Panel Questions and Discussion (28of35) Complex Generics – Sep. 25-26, 2019

Bryan Newman, Denise Conti, Kimberly Witzmann, Tian Ma, Fang Yuan, and Bhagwant Rege respond to audience questions.

CGIC2024 Day 2 Session: Identifying and Quantifying Sources of Variability

CGIC2024 Day 2 Session: Identifying and Quantifying Sources of Variability

In Critical Path Institute's (C-Path) Global Impact Conference 2024, Executive Director of C-Path's Duchenne Regulatory Science ...

GDF2025 - D2S15 - Questions & Panel Discussion - Session Three

GDF2025 - D2S15 - Questions & Panel Discussion - Session Three

The Generic Drugs Forum's third of four